Zentiva Leads the Way in Sustainable Pharmaceutical Practices

Acting Today for a Sustainable Tomorrow
Zentiva is proud to present its 2024 Sustainability Report, a detailed overview of initiatives and accomplishments aimed at promoting responsible healthcare practices. This year's report showcases the company's unwavering commitment to sustainability, social responsibility, and environmental stewardship, marking another significant milestone in its journey toward a cleaner, healthier future.
Commitment to Environmental Responsibility
A key highlight from this year's report indicates that Zentiva has successfully reduced greenhouse gas emissions in Scope 1 by more than 20% over the last three years. All manufacturing sites across Europe are now powered by 100% renewable electricity, demonstrating Zentiva's dedication to achieving its climate targets. By embracing renewable energy solutions, the company is actively contributing to Europe's ambition to become the first climate-neutral continent by 2050.
Sustainability Through Collaboration
Steffen Saltofte, CEO of Zentiva, emphasizes the importance of collaboration in achieving sustainability goals. He stated, "We at Zentiva exemplify how corporate growth can align with sustainable practices. We reach over 100 million people with our affordable, high-quality products. Our focus on minimizing environmental impact while enhancing workplace satisfaction exemplifies our dual commitment to social responsibility and sustainability."
A Culture of Inclusivity and Diversity
Zentiva operates in more than 30 countries, creating a diverse workforce that reflects various cultures and backgrounds. The organization has been recognized as a Top Employer in many of its key locations and has received the “Great Place to Work” certification in several others. With a gender balance of 53% women, Zenith's work environment supports equity and inclusivity, making it an appealing workplace for over 5,000 employees.
Non-Financial Reporting Standards
The sustainability report follows the Global Reporting Initiative (GRI) standards, highlighting non-financial topics that resonate with the company's strategic objectives in Environmental, Social, and Governance (ESG) areas. This transparency underscores Zentiva's commitment to progress across all facets of sustainability.
About Zentiva
Zentiva plays a vital role in promoting health and wellbeing across generations. The company develops, produces, and delivers high-quality, affordable medicines to more than 100 million people across its extensive network in over 30 countries. As a private equity-owned entity, Zentiva is not only focused on sustainable growth but also committed to securing a reliable supply of essential medications.
With roots over 500 years deep in a small pharmacy located in a historical area, Zentiva remains dedicated to its origins while looking forward to a sustainable future. The collective efforts of its diverse workforce contribute to maintaining this legacy, ensuring that generations to come will benefit from the company's core mission.
Frequently Asked Questions
What is the main focus of Zentiva's 2024 Sustainability Report?
The report emphasizes Zentiva's achievements in reducing greenhouse gas emissions and commitment to renewable energy, showcasing its alignment with European climate goals.
How many countries does Zentiva operate in?
Zentiva has operations in over 30 countries, illustrating its significant global presence and commitment to healthcare accessibility.
What recognition has Zentiva received regarding workplace culture?
Zentiva has been recognized as a Top Employer and received Great Place to Work certification, highlighting its dedication to fostering an inclusive work environment.
What is the gender balance in Zentiva's workforce?
The workforce at Zentiva maintains a gender balance of 53% women, emphasizing the company's commitment to diversity and inclusivity.
How can the public access Zentiva’s sustainability report?
The full Sustainability Report can be accessed through Zentiva's official website, where detailed insights and achievements are disclosed.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.